BridgeMD
New treatment option for Surgical Site Infection
Official title Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial
ClinicalTrials.gov ID: NCT06586749
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine if nurse-led education and tele-interventions can reduce the incidence of surgical wound infections in patients after coronary artery bypass surgery. The main questions it aims to answer are: Can nurse-led education reduce the rate of surgical wound infections after coronary artery bypass surgery?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Patients who have undergone CABG with median sternotomy
- Proficiency in reading and writing in Greek
- Patients who provide written informed consent for participation in the study
- Patients who have access to a mobile phone and know how to use it
You likely can't join if
- History of psychiatric illness, recent history of alcohol and/or substance abuse, dementia, and Alzheimer's disease
- Presence of an active infection within 2 weeks prior to the surgical procedure
- Preoperative hospitalization \> 2 days
- Concurrent surgery on the aorta or heart valves
- Urgent or emergency nature of the surgical procedure
- Re-sternotomy aimed at surgical re-exploration of bleeding or implementation of cardiopulmonary resuscitation (CPR) in cases of cardiac arrest
See the full eligibility criteria
- Age ≥ 18 years
- Patients who have undergone CABG with median sternotomy
- Proficiency in reading and writing in Greek
- Patients who provide written informed consent for participation in the study
- Patients who have access to a mobile phone and know how to use it
- Patients without difficulties in vision, speech, or hearing
- Patients at intermediate or high risk for developing surgical site infections, based on their scores in the risk stratification models described below
- History of psychiatric illness, recent history of alcohol and/or substance abuse, dementia, and Alzheimer's disease
- Presence of an active infection within 2 weeks prior to the surgical procedure
- Preoperative hospitalization \> 2 days
- Concurrent surgery on the aorta or heart valves
- Urgent or emergency nature of the surgical procedure
- Re-sternotomy aimed at surgical re-exploration of bleeding or implementation of cardiopulmonary resuscitation (CPR) in cases of cardiac arrest
- Patients in whom the sternum has not been closed after the completion of the surgical procedure and who are transferred to the cardiothoracic unit without sternum closure
- Active endocarditis
- Life expectancy \< 6 months
- Lack of a smartphone
The study team makes the final eligibility decision.
Where it's taking place
- Heraklion, Crete, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Heraklion, Crete, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.